383 related articles for article (PubMed ID: 29504478)
1. Targeting dysfunctional beta-cell signaling for the potential treatment of type 1 diabetes mellitus.
Fenske RJ; Kimple ME
Exp Biol Med (Maywood); 2018 Mar; 243(6):586-591. PubMed ID: 29504478
[TBL] [Abstract][Full Text] [Related]
2. Synergy Between Gαz Deficiency and GLP-1 Analog Treatment in Preserving Functional β-Cell Mass in Experimental Diabetes.
Brill AL; Wisinski JA; Cadena MT; Thompson MF; Fenske RJ; Brar HK; Schaid MD; Pasker RL; Kimple ME
Mol Endocrinol; 2016 May; 30(5):543-56. PubMed ID: 27049466
[TBL] [Abstract][Full Text] [Related]
3. The Inhibitory G Protein α-Subunit, Gαz, Promotes Type 1 Diabetes-Like Pathophysiology in NOD Mice.
Fenske RJ; Cadena MT; Harenda QE; Wienkes HN; Carbajal K; Schaid MD; Laundre E; Brill AL; Truchan NA; Brar H; Wisinski J; Cai J; Graham TE; Engin F; Kimple ME
Endocrinology; 2017 Jun; 158(6):1645-1658. PubMed ID: 28419211
[TBL] [Abstract][Full Text] [Related]
4. Agonist-independent Gα
Schaid MD; Green CL; Peter DC; Gallagher SJ; Guthery E; Carbajal KA; Harrington JM; Kelly GM; Reuter A; Wehner ML; Brill AL; Neuman JC; Lamming DW; Kimple ME
J Biol Chem; 2021; 296():100056. PubMed ID: 33172888
[TBL] [Abstract][Full Text] [Related]
5. Modulation of the pancreatic islet-stress axis as a novel potential therapeutic target in diabetes mellitus.
Ludwig B; Barthel A; Reichel A; Block NL; Ludwig S; Schally AV; Bornstein SR
Vitam Horm; 2014; 95():195-222. PubMed ID: 24559919
[TBL] [Abstract][Full Text] [Related]
6. Glucagon-like peptide 1 receptor agonist ameliorates the insulin resistance function of islet β cells via the activation of PDX-1/JAK signaling transduction in C57/BL6 mice with high-fat diet-induced diabetes.
Hao T; Zhang H; Li S; Tian H
Int J Mol Med; 2017 Apr; 39(4):1029-1036. PubMed ID: 28290604
[TBL] [Abstract][Full Text] [Related]
7. Ghrelin mitigates β-cell mass loss during insulitis in an animal model of autoimmune diabetes mellitus, the BioBreeding/Worcester rat.
Baena-Nieto G; Lomas-Romero IM; Mateos RM; Leal-Cosme N; Perez-Arana G; Aguilar-Diosdado M; Segundo C; Lechuga-Sancho AM
Diabetes Metab Res Rev; 2017 Jan; 33(1):. PubMed ID: 27103341
[TBL] [Abstract][Full Text] [Related]
8. Prolactin as an Adjunct for Type 1 Diabetes Immunotherapy.
Hyslop CM; Tsai S; Shrivastava V; Santamaria P; Huang C
Endocrinology; 2016 Jan; 157(1):150-65. PubMed ID: 26512750
[TBL] [Abstract][Full Text] [Related]
9. Long-term liraglutide treatment is associated with increased insulin content and secretion in β-cells, and a loss of α-cells in ZDF rats.
Schwasinger-Schmidt T; Robbins DC; Williams SJ; Novikova L; Stehno-Bittel L
Pharmacol Res; 2013 Oct; 76():58-66. PubMed ID: 23891763
[TBL] [Abstract][Full Text] [Related]
10. beta-cell failure in diabetes and preservation by clinical treatment.
Wajchenberg BL
Endocr Rev; 2007 Apr; 28(2):187-218. PubMed ID: 17353295
[TBL] [Abstract][Full Text] [Related]
11. Activated protein C and its potential applications in prevention of islet β-cell damage and diabetes.
Xue M; Jackson CJ
Vitam Horm; 2014; 95():323-63. PubMed ID: 24559924
[TBL] [Abstract][Full Text] [Related]
12. Protection of pancreatic beta-cells: is it feasible?
Bonora E
Nutr Metab Cardiovasc Dis; 2008 Jan; 18(1):74-83. PubMed ID: 18096375
[TBL] [Abstract][Full Text] [Related]
13. Activation of the GLP-1 receptor signalling pathway: a relevant strategy to repair a deficient beta-cell mass.
Portha B; Tourrel-Cuzin C; Movassat J
Exp Diabetes Res; 2011; 2011():376509. PubMed ID: 21716694
[TBL] [Abstract][Full Text] [Related]
14. GABA exerts protective and regenerative effects on islet beta cells and reverses diabetes.
Soltani N; Qiu H; Aleksic M; Glinka Y; Zhao F; Liu R; Li Y; Zhang N; Chakrabarti R; Ng T; Jin T; Zhang H; Lu WY; Feng ZP; Prud'homme GJ; Wang Q
Proc Natl Acad Sci U S A; 2011 Jul; 108(28):11692-7. PubMed ID: 21709230
[TBL] [Abstract][Full Text] [Related]
15. An update on preventive and regenerative therapies in diabetes mellitus.
Reimann M; Bonifacio E; Solimena M; Schwarz PE; Ludwig B; Hanefeld M; Bornstein SR
Pharmacol Ther; 2009 Mar; 121(3):317-31. PubMed ID: 19168093
[TBL] [Abstract][Full Text] [Related]
16. Puerarin Protects Pancreatic β-Cells in Obese Diabetic Mice via Activation of GLP-1R Signaling.
Yang L; Yao D; Yang H; Wei Y; Peng Y; Ding Y; Shu L
Mol Endocrinol; 2016 Mar; 30(3):361-71. PubMed ID: 26789107
[TBL] [Abstract][Full Text] [Related]
17. Reversal of new-onset diabetes through modulating inflammation and stimulating beta-cell replication in nonobese diabetic mice by a dipeptidyl peptidase IV inhibitor.
Tian L; Gao J; Hao J; Zhang Y; Yi H; O'Brien TD; Sorenson R; Luo J; Guo Z
Endocrinology; 2010 Jul; 151(7):3049-60. PubMed ID: 20444936
[TBL] [Abstract][Full Text] [Related]
18. Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells.
Sherry NA; Chen W; Kushner JA; Glandt M; Tang Q; Tsai S; Santamaria P; Bluestone JA; Brillantes AM; Herold KC
Endocrinology; 2007 Nov; 148(11):5136-44. PubMed ID: 17673522
[TBL] [Abstract][Full Text] [Related]
19. Neurturin and a GLP-1 Analogue Act Synergistically to Alleviate Diabetes in Zucker Diabetic Fatty Rats.
Trevaskis JL; Sacramento CB; Jouihan H; Ali S; Le Lay J; Oldham S; Bhagroo N; Boland BB; Cann J; Chang Y; O'Day T; Howard V; Reers C; Winzell MS; Smith DM; Feigh M; Barkholt P; Schreiter K; Austen M; Andag U; Thompson S; Jermutus L; Coghlan MP; Grimsby J; Dohrmann C; Rhodes CJ; Rondinone CM; Sharma A
Diabetes; 2017 Jul; 66(7):2007-2018. PubMed ID: 28408435
[TBL] [Abstract][Full Text] [Related]
20. Protein Kinase CK2-A Putative Target for the Therapy of Diabetes Mellitus?
Ampofo E; Nalbach L; Menger MD; Montenarh M; Götz C
Int J Mol Sci; 2019 Sep; 20(18):. PubMed ID: 31500224
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
